1. Market Research
  2. > Healthcare Market Trends
Global Albumin Market: Size, Trends & Forecasts (2018-2022)

Global Albumin Market: Size, Trends & Forecasts (2018-2022)

  • January 2018
  • 53 pages
  • ID: 5304257


Table of Contents

Search Inside

Scope of the Report
The report entitled “Global Albumin Market: Size, Trends & Forecasts (2018-2022)”, provides analysis of the global albumin market, with detailed analysis in terms of value, volume and per capita consumption of Albumin in various countries worldwide. Also, an analysis of major players in the market in terms of volume of albumin supplied by them has also been done.

The report also includes a brief regional analysis of China albumin market. Under competitive landscape, different players present in the albumin market have been compared on the basis of market share.

Moreover, the report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall albumin market has also been forecasted for the years 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

CSL Limited, Shire Plc, Grifols SA and Octapharma AG are some of the key players operating in the global albumin market whose company profiling is done in the report. In this segment of the report, business overview, financial overview and the business strategies of the companies are provided.

Company Coverage
CSL Limited
Shire Plc
Grifols SA
Octapharma AG

Executive Summary
Blood plasma is the liquid constituent of the blood. It is responsible for holding the blood cells in whole blood suspension. Albumin is one of the segments of blood plasma while the others are immunoglobulin, alpha1 and factor 8 proteins.

Albumin is a globular protein soluble in water and its production takes place in the liver. It is an important constituent of blood plasma. Blood plasma Albumin is used for treating patients with blood related health issues such as hypoalbuminemia (low albumin), hypovolemic (low blood volume), acute respiratory distress syndrome (ARDS), burns, nephrosis, renal dialysis, acute liver failure, cardiopulmonary bypass surgery and hemolytic disease of the newborn.

The albumin can be segmented on the basis of type and applications. On the basis of type, the albumin can be split into human serum albumin and recombinant serum albumin. On the basis of application, albumin can be sub segmented into four categories such as cell culture, vaccines, blood volumizer and drug delivery.

The global albumin market is anticipated to grow at a healthy rate during the forecast period (2018-2022). The market is supported by various growth drivers such as spike in ageing population, boost in number of plasma donation centers and increasing use of albumin for the treatment of Alzheimer patients. However, the high pricing pressure faced by the major players operating in the global albumin market is a major challenge.

However, acceleration in use of albumin for non therapeutic applications, ease of packaging and potential growth opportunities in China are some of the latest trends existing in the market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Plasma Fractionation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Plasma Fractionation Industry: Forecasts to 2026

  • $ 5795
  • Industry report
  • August 2018
  • by Transparency Market Research

Global Plasma Fractionation Market - OverviewRising demand for plasma proteins, increasing investment in innovation and rising prevalence of rare diseases across the world are major factors that are expected ...

Global Blood Collection and Processing Supplies Industry

Global Blood Collection and Processing Supplies Industry

  • $ 5600
  • Industry report
  • August 2018
  • by Global Industry Analysts

This report analyzes the worldwide markets for Blood Collection and Processing Supplies in US$ by the following Product Segments: Blood Administration Sets, Blood Collection Needles, Blood Collection Tubes ...

Leukapheresis Market by Product, Leukopak, Application, End User - Global Forecast to 2023

Leukapheresis Market: Global Forecast until 2023

  • $ 5649
  • Industry report
  • August 2018
  • by MarketsandMarkets

The leukapheresis products and leukopaks markets are projected to grow at a CAGR of 7.4% and 46.4%, respectively.The leukapheresis products market is expected to reach USD 27.7 million by 2023 from an ...


Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on